Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains.
about
Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Linezolid for the treatment of drug-resistant infections.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Nocardia Arthritis: 3 Cases and Literature Review.Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression ModelsPharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.Pharmacologic options for CNS infections caused by resistant Gram-positive organisms.Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.Bacterial meningitis: new therapeutic approaches.Bacterial meningitis: an update of new treatment options.Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluidThe Use of Daptomycin and Linezolid to Treat Vancomycin-Intermediate Staphylococcus haemolyticus Infection in a Premature Infant.Neuroprotective potential of Linezolid: a quantitative and distribution study via mass spectrometry.Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitroClinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.
P2860
Q34142328-11EFEDC2-EB14-4E7A-AAAA-72CF7950CFC8Q34157657-E4824722-3880-4633-88F8-E0DA36460826Q34894133-574554A4-2357-40F3-AF10-BFB3B2B8D20DQ36083208-D6DC0A72-F70C-4624-870B-F02018F2496FQ36206815-F771CCEC-EA8C-4BBB-B878-4569220A50C7Q36620071-D100F672-D56B-466E-82D8-E73AE514EFCDQ36777850-7B57AF7E-2A69-400F-8E1F-C4610F361AFAQ37077629-BCCE80DF-6CEF-4EAB-9E82-5EDCDA8C68D2Q37869258-0E431B84-493B-4343-950C-34226A8722ACQ38100704-9BA03311-499B-4828-AB09-25ECECEAE11FQ38145360-59289E76-0847-492E-95BE-31BFD3CACAB9Q38570487-AB693A05-CF7B-4203-9E8E-B19A17DC3D39Q40600560-D5D80267-96A8-4266-84EA-C30E5541F583Q41990854-3D4B442E-EAE2-4828-BC78-682BB5499727Q42101970-F193E42B-31F4-4B06-825E-1029F4118CEAQ42189707-7074400A-4306-4ADF-B96B-0A8B6E6373E4Q47611899-BCF4210C-6F10-4EFB-9156-922951D64395
P2860
Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pharmacokinetics of intravenou ...... h external ventricular drains.
@ast
Pharmacokinetics of intravenou ...... h external ventricular drains.
@en
type
label
Pharmacokinetics of intravenou ...... h external ventricular drains.
@ast
Pharmacokinetics of intravenou ...... h external ventricular drains.
@en
prefLabel
Pharmacokinetics of intravenou ...... h external ventricular drains.
@ast
Pharmacokinetics of intravenou ...... h external ventricular drains.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of intravenou ...... h external ventricular drains.
@en
P2093
Apostolos Georgopoulos
Bettina Pfausler
Christian Brenneis
Erich Schmutzhard
Gregor Broessner
Klaus W Engelhardt
Peter Lackner
Raimund Helbok
Ronny Beer
Stefan T Kaehler
P2860
P304
P356
10.1128/AAC.00515-06
P407
P577
2006-10-16T00:00:00Z